Edition:
India

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

1.78USD
19 Oct 2018
Change (% chg)

$-0.15 (-7.77%)
Prev Close
$1.93
Open
$1.92
Day's High
$1.93
Day's Low
$1.74
Volume
20,395
Avg. Vol
81,964
52-wk High
$4.09
52-wk Low
$1.49

Chart for

About

Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company’s lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response... (more)

Overall

Beta: --
Market Cap(Mil.): $100.36
Shares Outstanding(Mil.): 52.27
Dividend: --
Yield (%): --

Financials

BRIEF-Sierra Oncology Reports Qtrly Loss Per Share $0.19

* SIERRA ONCOLOGY INC - SRA737 MONOTHERAPY PHASE 1/2 TRIAL EXPANDED TO ENROLL CCNE1-DRIVEN OVARIAN CANCER COHORT

10 May 2018

Earnings vs. Estimates